Actual and preferred place of death of cancer patients. Results from the Italian survey of the dying of cancer (ISDOC).

Journal of Epidemiology and Community Health
Monica BeccaroISDOC Study Group

Abstract

To describe actual and preferred place of death of Italian cancer patients and to analyse the preferences met regarding the place of death. Mortality follow back survey of 2000 cancer deaths, identified with a two stage probability sample representative of the whole country. Information on patients' experience was gathered from the non-professional caregiver with an interview. A section of the interview covered information on the actual and preferred place of death of the patients. 30 Italian local health districts randomly selected after stratification in four geographical areas. 1900 of 2000 (95.0%) caregivers of cancer deaths identified. Prevalence of actual and preferred places of death. Valid interviews were obtained for 66.9% (n = 1271) of the caregivers. Place of death was home for 57.9% of Italian cancer patients, hospital for 34.6%, hospice for 0.7%, nursing home for 6.5%, and ambulance for 0.4%. Wide and significant differences within Italy were seen (home deaths ranged between 94.0% in the south and 28.2% in the north east). Home was the preferred place of death for 93.5% of patients that expressed a preference, with minimal differences within the country (between 89.5% and 99.0%). Overall 67.1% of the sample died in...Continue Reading

References

Sep 1, 1990·BMJ : British Medical Journal·J TownsendM Piper
Jan 1, 1996·The Hospice Journal·O Gilbar, M Steiner
Sep 23, 1998·Palliative Medicine·S Karlsen, J Addington-Hall
Sep 6, 2000·Social Science & Medicine·C Seale
Oct 10, 2002·The Lancet Oncology·Michael Jefford, Martin H N Tattersall
Nov 19, 2002·Social Science & Medicine·C J McPherson, J M Addington-Hall
Sep 11, 2003·Annals of Internal Medicine·Donald L PatrickEllen McCown
Apr 15, 2004·Social Science & Medicine·C ThomasD Clark
Dec 8, 2004·Critical Reviews in Oncology/hematology·Antonella SurboneAntonio G Spagnolo
Jul 27, 2005·Journal of Pain and Symptom Management·Franco ToscaniUNKNOWN End-of-Life Observatory Group
Oct 13, 2005·Palliative Medicine·Kevin BrazilChristine Heidebrecht

❮ Previous
Next ❯

Citations

Feb 26, 2008·Intensive Care Medicine·Alberto GianniniStefania Leoncino
Feb 23, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kazuki SatoYasuo Shima
Oct 22, 2013·Lancet·Massimo CostantiniUNKNOWN Liverpool Care Pathway Italian Cluster Trial Study Group
Dec 19, 2012·Nature Reviews. Clinical Oncology·Gabrielle B Rocque, James F Cleary
Oct 19, 2011·Journal of Palliative Medicine·Luis Carlos Escobar PinzonMartin Weber
Sep 12, 2013·Journal of Palliative Medicine·Jennifer A BlechmanVyjeyanthi S Periyakoil
Sep 4, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S T TangT-W Liu
Nov 15, 2007·Journal of Epidemiology and Community Health·Joachim CohenUNKNOWN EURELD Consortium
Aug 24, 2012·BMC Family Practice·Maria C De Korte-VerhoefLuc Deliens
Mar 28, 2013·BMC Palliative Care·Aderaw AntenehAwoke Misganaw
Jun 10, 2010·BMC Palliative Care·Marina CasadioFranco Pannuti
Jan 26, 2011·BMC Health Services Research·Massimo CostantiniUNKNOWN LCP Randomised Italian Cluster Trial Study Group
Feb 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alberto Alonso-BabarroManuel González-Barón
Jun 27, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neha JeurkarDavid J Casarett
Mar 2, 2012·Journal of Oncology Practice·J Russell Hoverman
May 2, 2013·Journal of Oncology Practice·Gabrielle B RocqueJames F Cleary
Feb 3, 2011·Healthcare Policy = Politiques De Santé·Lisa BarberaLawrence Paszat
Apr 18, 2012·PloS One·Marjolein GyselsUNKNOWN Project PRISMA
Aug 18, 2009·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Koen MeeussenLuc Deliens
Aug 16, 2014·Indian Journal of Palliative Care·Priyadarshini KulkarniRavindra Ghooi
Oct 30, 2012·Journal of Pain and Symptom Management·Sebastiano MercadanteUNKNOWN Home Care—Italy Group
Jun 2, 2012·Journal of Pain and Symptom Management·Sebastiano MercadanteUNKNOWN Home Care–Italy Group (HOCAI)
May 31, 2011·Journal of Pain and Symptom Management·Sebastiano MercadanteUNKNOWN Home Care—Italy (HOCAI) Group
Jun 15, 2010·Journal of Pain and Symptom Management·Siew Tzuh TangTsang-Wu Liu
Jun 29, 2010·Journal of Pain and Symptom Management·Siew Tzuh TangShiao-Chi Wu
May 15, 2010·Gynecologic Oncology·L BarberaA S Bierman
Feb 2, 2010·Journal of Pain and Symptom Management·Christina L BellKamal H Masaki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Joachim CohenLuc Deliens
Journal of Pain and Symptom Management
F ToscaniEnd-of-Life Observatory Group
© 2022 Meta ULC. All rights reserved